InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Martin Patricia A.. Director active across 2 companies, notably AN2 Therapeutics, Inc.. Aggregated, 8 filings have been published. History available since 19 December 2024. The latest transaction was filed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Martin Patricia A. is a declarant linked to AN2 Therapeutics, Inc., where the listed role is Director. The record shows 4 filings in total, and the 4 sampled filings span from 2024-12-23 to 2026-04-10, with the transaction nature listed as Attribution and buy and sell amounts of 0.